<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01296308</url>
  </required_header>
  <id_info>
    <org_study_id>10-4517</org_study_id>
    <nct_id>NCT01296308</nct_id>
  </id_info>
  <brief_title>Complementary and Integrative Therapy for Diabetic Neuropathy</brief_title>
  <acronym>CIT-DN</acronym>
  <official_title>Effectiveness of a Complementary and Integrative Therapy in Diabetic Neuropathy Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universität Duisburg-Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universität Duisburg-Essen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the long tradition of complementary and alternative medicine (CAM) therapies there
      are hardly any interventional trials on type 2 diabetes mellitus. Hence this pilot study aims
      to investigate the influence of a two weeks integrative inpatient therapy on the quality of
      life in 50 patients suffering from diabetic neuropathy. Integrative treatment includes
      aspects of conventional and traditional European and Chinese medicine, mind-body medicine,
      physical therapy and lifestyle modification (nutrition advices, stress management and
      exercise training). The observational design intends four measurement points: tree months
      before (T0), directly before (T1), directly after treatment (T2) and three months follow-up
      (T3). The subjective evaluation of the neuropathy-related quality of life was combined with
      neurophysiologic instruments (QST), to measure neuropathic symptoms. Also pain intensity,
      locus of control, interpretation of illness, coping style, anxiety/depression, life
      satisfaction and several biomarkers (HbA1c, ABI, WHR and BMI) are measured. In addition a
      qualitative interview should give a view to patient perspective of therapy process.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neuropathy-related Quality of Life (QOL-DN)</measure>
    <time_frame>at T2</time_frame>
    <description>Norfolk Quality of Life Questionnaire (Vinik et al. 2008)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropathy-related Quality of Life (QOL-DN)</measure>
    <time_frame>at T3</time_frame>
    <description>Norfolk Quality of Life Questionnaire (Vinik et al. 2008)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantitative Sensory Testing (QST)</measure>
    <time_frame>at T2 and T3</time_frame>
    <description>Thermal detection thresholds (CDT, WDT), thermal pain thresholds (CPT, HPT) and paradoxical heat sensations (PHS)
Mechanical detection threshold (MDT), mechanical pain threshold (MPT), mechanical pain sensitivity (MPS), dynamic mechanical allodynia (ALL) and wind-up ratio (WUR)
Vibration detection threshold (VDT)
Pressure pain threshold (PPT) (Rolke et al. 2006)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity (VAS)</measure>
    <time_frame>at T2 and T3</time_frame>
    <description>100mm Visual Analogue Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Control Beliefs (MHLC / short form)</measure>
    <time_frame>at T2 and T3</time_frame>
    <description>Short form of the Multidimensional Helath Locus of Control Scale (Hasenbring 1988)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interpretation of Illness (IIQ)</measure>
    <time_frame>at T2 and T3</time_frame>
    <description>Interpretation of Illness Questionnaire (Büssing et al. 2009)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping Style (AKU)</measure>
    <time_frame>at T2 and T3</time_frame>
    <description>Short form of the Adaptive Coping with Disease Questionnaire (Büssing et al. 2010)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and Depression (HADS)</measure>
    <time_frame>at T2 and T3</time_frame>
    <description>Hospital Anxiety and Depression Scale (Herrmann et al. 1995)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life Satisfaction (SWLS)</measure>
    <time_frame>at T2 and T3</time_frame>
    <description>Satisfaction with Life Scale (Diener et al. 1995)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood sugar Level (HbA1c)</measure>
    <time_frame>at T2 and T3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist-to-Hip Ratio (WHR) and Body Mass Index (BMI)</measure>
    <time_frame>at T2 and T3</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">6</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Diabetic Neuropathy</condition>
  <arm_group>
    <arm_group_label>type 2 diabetics with neuropathy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>inpatient integrative treatment</intervention_name>
    <description>two weeks inpatient integrative therapy: conventional medicine, traditional European and Chinese medicine (TCM), mind-body medicine, physical therapy, lifestyle modification program: nutrition advices, stress management, exercise training</description>
    <arm_group_label>type 2 diabetics with neuropathy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 18 years old

          -  diabetes mellitus type 2

        Exclusion Criteria:

          -  diabetes mellitus type 1

          -  pregnancy

          -  oncologic diseases

          -  systemic neurological diseases

          -  other induced neuropathy (radicular, s/p alcohol abuse, chemotherapy-induced)

          -  other severe psychiatric or somatic comorbidity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustav J. Dobos, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Duisburg-Essen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kliniken Essen-Mitte</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2011</study_first_submitted>
  <study_first_submitted_qc>February 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2011</study_first_posted>
  <last_update_submitted>July 16, 2012</last_update_submitted>
  <last_update_submitted_qc>July 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universität Duisburg-Essen</investigator_affiliation>
    <investigator_full_name>Heidemarie Haller</investigator_full_name>
    <investigator_title>MSc</investigator_title>
  </responsible_party>
  <keyword>Diabetes Mellitus, Type 2</keyword>
  <keyword>Diabetic Neuropathy</keyword>
  <keyword>Complementary Medicine</keyword>
  <keyword>Alternative Medicine</keyword>
  <keyword>Integrative Medicine</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Quantitative Sensory Testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

